Target intelligence / Profile preview

Tissue Vasculature

Molecular classification
Other
01

Overview

Tissue vasculature refers to the complex network of blood vessels, including arteries, veins, and capillaries, that permeate tissues to provide oxygen and nutrients while removing metabolic waste (NIH, 2023). It plays a fundamental role in physiological processes such as thermoregulation, immune surveillance, and the maintenance of blood pressure (StatPearls, 2023). In many pathological states, particularly cancer, the vasculature is co-opted or remodeled; for instance, tumors induce angiogenesis to sustain their rapid growth and facilitate metastasis (PubMed, 2021). Therapeutic strategies targeting the vasculature often focus on inhibiting these growth signals, such as the Vascular Endothelial Growth Factor (VEGF) pathway, or modulating vessel function to improve drug delivery. Beyond oncology, the vasculature is a primary focus in treating cardiovascular diseases, where drugs aim to manage vascular tone and prevent the formation of obstructive clots (PubMed, 2022). Because the vasculature is a systemic network, pharmacological interventions can lead to significant side effects, including hypertension, impaired wound healing, and hemorrhage (NIH, 2023).

Other names
Blood vesselsVascular systemMicrovasculatureEndothelium
02

Mechanism of action

Inhibition of vascular endothelial growth factor (VEGF) signaling, inhibition of receptor tyrosine kinases (RTKs), modulation of nitric oxide levels for vasodilation, blockade of calcium channels in vascular smooth muscle, and inhibition of coagulation factors within the vascular lumen.

03

Biological functions

Oxygen and nutrient transportWaste removalThermoregulationImmune cell traffickingHemostasisBlood pressure regulation
04

Disease associations

CancerCardiovascular diseaseDiabetesInflammationHypertensionAge-related macular degeneration
05

Safety considerations

HypertensionHemorrhageArterial thromboembolismImpaired wound healingProteinuriaGastrointestinal perforation
06

Interacting drugs

Bevacizumab

6 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF)Circulating endothelial cells (CECs)Soluble VEGFR-2Ktrans (DCE-MRI parameter)

Beyond the preview

Go deeper on Tissue Vasculature.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue Vasculature.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call